Clorox (NYSE: CLX) reported Q2 EPS of $1.40, $0.10 better than the analyst estimate of $1.30. Revenue for the quarter came in at $1.47 billion versus the consensus estimate of $1.47 billion.

Fiscal Second-Quarter Results

Following is a summary of key second-quarter results. All comparisons are with the second quarter of fiscal year 2018, unless otherwise stated.

• 4% sales growth
• $1.40 diluted EPS (21% decrease)

"Sound execution of our pricing and cost-savings plans has enabled us to address near-term headwinds, resulting in another strong quarter of topline performance," said Clorox Chair and CEO Benno Dorer. "Importantly, we remain on track for sales and earnings in fiscal year 2019."

"With pricing largely behind us, we\'re focused on ongoing investment in our brands through robust back-half innovation, behind significant advertising and sales promotion support," Dorer added. "We have continued confidence in our ability to deliver long-term value for our shareholders, guided by our 2020 Strategy, with an emphasis on innovation, brands with purpose and superior value, and leadership in digital."

GUIDANCE:

Clorox sees FY2019 EPS of $6.20-$6.40, versus the consensus of $6.32.

For earnings history and earnings-related data on Clorox (CLX) click here.